CCAR2 and type 2 diabetes mellitus: As SIRT1 is known to regulate glucose/lipid homeostasis and energy expenditure in the liver, CCAR2, the endogenous inhibitor of SIRT1, may have potential implications in T2DM pathogenesis[44].